Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Ireland agrees deal to buy one million vaccines from Romania

Fri, 02nd Jul 2021 16:11

(Alliance News) - Ireland has agreed a deal in principle to purchase one million unwanted vaccines from Romania.

Taoiseach Micheal Martin spoke to the president of Romania, Klaus Iohannis, on Friday and a deal was agreed, but is yet to be finalised.

It will provide a further boost for Ireland's vaccination rollout, following an earlier announcement that it will be accelerated for people aged 18 to 34.

A spokesman for the taoiseach said: "The taoiseach has consistently been making every effort and working with his counterparts across Europe to increase the number of vaccines made available to Ireland.

"As part of this process the taoiseach had a good discussion this morning with his EU counterpart, Romanian president Klaus Iohannis, and they agreed in principle to the purchase of one million vaccines.

"This process is continuing and is yet to be completed. He will continue to work with his government colleagues to expedite the vaccine programme.

"This includes discussions with the European Commission and with member states, particularly those who may have potential surpluses.

"Ensuring that as many people as possible can get vaccinated as quickly as possible remains the best way to combat Covid-19, particularly given the rapid rise of the Delta variant."

The PA news agency understands that the purchase will be made up of the mRNA vaccines Pfizer and Moderna.

Earlier it was announced that people aged 18 to 34 could receive their coronavirus vaccine up to two months early under an accelerated programme announced by the Minister for Health.

It follows updated advice from the National Immunisation Advisory Committee that the AstraZeneca PLC and Johnson & Johnson vaccines can be given to people under 40.

People aged 18 to 34 can now "opt in" for one of those jabs, or choose to wait for an mRNA vaccine such as Pfizer Inc or Moderna Inc.

The opt-in system will run in parallel with the online registration portal, which will open for the 30 to 34-year-old age cohort next Friday.

Health Minister Stephen Donnelly told the Dail that "a significant acceleration of the vaccine programme" will begin from Monday.

He said: "In short, the changes that we're implementing from Monday will mean that the 18 to 34-year-old age group will have the option of being vaccinated one to two months early.

"And that would have been really, really welcome regardless of the Delta variant and this surge, but particularly in light of the modelling we saw from Professor Nolan's team as to what is likely to happen here through August and September in particular.

"To be able to pull forward a huge number of people from September to August, and some from August into July, is incredibly valuable.

"It's really going to help us protecting each other and protect our population from the Delta surge that we know is coming."

It comes after Chief Medical Officer Tony Holohan warned a fourth wave of Covid-19, driven by the Delta variant, cannot be stopped, and will lead to higher levels of hospital admissions and death.

The accelerated vaccine rollout will fail to halt an exponential rise in cases in July and August, he said, but should help bring the situation under control in September.

Donnelly said: "Supplies of Janssen (J&J) and AstraZeneca will be somewhat limited during July, but we expect that supplies will be able to accommodate a significant number of this age group through July."

He said up to 210,000 J&J vaccines will be available in July.

Another 100,000 AstraZeneca jabs will be available, after the outstanding second doses have been administered.

"The company is committed to providing significantly higher amounts than that," Donnelly added.

Donnelly said the estimate for people aged 25 to 29 to get their first dose, should they wait for mRNA, would be early August, with people aged 18 to 24 waiting until mid-August.

That means it would be early to mid-September before they get their second dose and are fully vaccinated.

The accelerated rollout is take to place in pharmacies and vaccination centres across the country.

Donnelly said: "People will be able to seek an appointment in one of over 700 pharmacies across the country for a Janssen vaccine, subject to supply.

"The following week, the week of the 12th of July, 18 to 34-year-olds will also be able to register on the HSE portal for an appointment in a vaccine centre for an earlier vaccination.

"In the main that will be AstraZeneca, and there will be some Janssen supply available as well. The point is, they'll then be vaccinated earlier than if they waited for the mRNA vaccine."

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.